Pentamidine isethionate and Hypersensitivity - a phase IV clinical study of FDA data

Summary:

Hypersensitivity is reported as a side effect among people who take Pentamidine isethionate (pentamidine isethionate), especially for people who are male, 40-49 old, have been taking the drug for < 1 month also take Truvada, and have Hiv infection.

The phase IV clinical study analyzes which people have Hypersensitivity when taking Pentamidine isethionate. It is created by eHealthMe based on reports of 1,965 people who have side effects when taking Pentamidine isethionate from the FDA, and is updated regularly.

What is Pentamidine isethionate?

Pentamidine isethionate has active ingredients of pentamidine isethionate. eHealthMe is studying from 1,967 Pentamidine isethionate users. Check the latest studies of Pentamidine isethionate.

What is Hypersensitivity?

Hypersensitivity is found to be associated with 2,750 drugs and 2,915 conditions by eHealthMe. Check the latest studies of Hypersensitivity.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

1,965 people reported to have side effects when taking Pentamidine isethionate.
Among them, 22 people (1.12%) have Hypersensitivity.

Could Pentamidine isethionate cause Hypersensitivity?

Among these 22 people:

How long have people been on Pentamidine isethionate when they have Hypersensitivity? *

What is the gender of people who have Hypersensitivity when taking Pentamidine isethionate? *

female: 38.1 %
male: 61.9 %

What is the age of people who have Hypersensitivity when taking Pentamidine isethionate? *

What are other drugs people take besides Pentamidine isethionate? *

What are other side effects people have besides Hypersensitivity? *

Fever: 13 people, 59.09%
Thrombocytopenia (decrease of platelets in blood): 9 people, 40.91%
Acute Kidney Failure: 8 people, 36.36%
Hypotension (abnormally low blood pressure): 7 people, 31.82%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 7 people, 31.82%
Dehydration (dryness resulting from the removal of water): 6 people, 27.27%
Pneumonia: 6 people, 27.27%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 6 people, 27.27%
Encephalopathy (functioning of the brain is affected by some agent or condition): 6 people, 27.27%
Diarrhea: 6 people, 27.27%

What are the existing conditions these people have? *

Hiv Infection: 6 people, 27.27%
Cough: 5 people, 22.73%
Pneumocystis Jiroveci Pneumonia (fungal infection of the lungs): 4 people, 18.18%
Oral Candidiasis (fungal infection of mouth): 4 people, 18.18%
Pneumocystis Carinii Pneumonia (pneumonia occurring in infants or in persons with impaired immune systems): 1 person, 4.55%
Hiv Infection Cdc Category C3: 1 person, 4.55%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 1 person, 4.55%
Acute Lymphocytic Leukaemia Recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Pentamidine isethionate and have Hypersensitivity?

- Check whether Hypersensitivity is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pentamidine isethionate:

Pentamidine isethionate (1,967 reports)

Hypersensitivity treatments and more:

Hypersensitivity (272,618 reports)

Browse all side effects of Pentamidine isethionate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hypersensitivity:

Hypersensitivity (2,750 drugs)

Browse all the conditions that are associated with Hypersensitivity:

Hypersensitivity (2,915 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pentamidine isethionate (the active ingredients of Pentamidine isethionate) and Pentamidine isethionate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.